Inhibition of protein disulfide isomerases as a strategy for reduction of prothrombotic state in atherosclerosis; therapeutic implications

2021/43/D/NZ7/03366

Keywords

Descriptors

  • NZ7_014: Farmacja, farmakoterapia, farmakologia

Panel

NZ7 – Diagnostic tools, therapies and public health: public health, epidemiology, environmental health risks and occupational medicine, medical ethics, drug discovery and therapies, pharmacology

Host institution

Uniwersytet Jagielloński, Jagiellońskie Centrum Rozwoju Leków (JCET)

Voivodeship: małopolskie

Other projects carried out by the institution »

Principal investigator (from the host institution)

dr Kamil Przyborowski

Number of co-investigators in the project: 5

Call

SONATA 17 – announced on 2021-09-15

Amount awarded
1 657 204 PLN
Project start date
2022-08-03
Project end date
2026-08-02
Project duration
48 months (the same as in the proposal)
Project status
Pending project

Project description

Download the project description in a pdf file

Note — project descriptions were prepared by the authors of the applications themselves and placed in the system in an unchanged form.

Information in the final report

Publication in academic press/journals (1)

  1. Protein disulfide isomerase 1 (PDIA1) regulates platelet-derived extracellular vesicle release

    Authors:
    Agnieszka Pelesz ,Katarzyna Rafa-Zablocka, Patrycja Kaczara, Stefan Chlopicki, Kamil Przyborowski
    Academic press:
    Thrombosis Research (year: 2025, volume: 245:109209, pages: 46033), Publisher: Elsevier
    Status:
    Published
    DOI:
    10.1016/j.thromres.2024.109209 – link to the publication

« New search

Graphic design and implementation: Jakub Piotrowski